Study of 0444 Gel in the Treatment of Inflammatory Lesions of Rosacea

Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel Group Study of 0444 Gel

The aim of this trial is to assess the efficacy of Metronidazole Topical Gel 1% in the Treatment of Inflammatory Lesions of Rosacea.

Treatment medication will be administered as follows: A thin film of gel will be applied and rubbed into the entire face once daily for a period of 70 days.

Inclusion Criteria:

• Clinical diagnosis of rosacea
• Good health with the exception of rosacea
• Papsules and pustules minimum and maximum requirements

Exclusion Criteria:

• Subjects who are pregnant, nursing, or planning a pregnancy within the study participation period.
• Subjects who have any systemic or dermatological disorders with the exception of rosacea